GlaxoSmithKline PLC
F:GS7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
GlaxoSmithKline PLC
F:GS7
|
UK |
|
I
|
Innate Pharma SA
SWB:IDD
|
FR |
|
T
|
Teekay Tankers Ltd
LSE:0EAQ
|
CA |
|
D
|
Douyu International Holdings Ltd
F:DY8A
|
CN |
|
H
|
Hackett Group Inc
F:AWT
|
US |
|
J
|
JinkoSolar Holding Co Ltd
XMUN:ZJS1
|
CN |
|
K
|
Kohls Corp
LSE:0JRL
|
US |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
F:AILA
|
FR |
|
Lagardere SA
F:LAG
|
FR |
|
K
|
Koninklijke DSM NV
F:DSM2
|
NL |
Wall St Price Targets
GS7 Price Targets Summary
GlaxoSmithKline PLC
According to Wall Street analysts, the average 1-year price target for GS7 is 17.49 EUR with a low forecast of 12.22 EUR and a high forecast of 24.02 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GS7's stock price target?
Price Target
17.49
EUR
According to Wall Street analysts, the average 1-year price target for GS7 is 17.49 EUR with a low forecast of 12.22 EUR and a high forecast of 24.02 EUR.
What is the Revenue forecast for GlaxoSmithKline PLC?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Operating Income forecast for GlaxoSmithKline PLC?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Net Income forecast for GlaxoSmithKline PLC?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 8 years is 4%.
